Clinical Trial Update: OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing optimal dosing of oral anticancer drugs in older adults, with multiple cancer indications listed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Carcinoma
• Endometrium Carcinoma
• Ovarian Carcinoma
• Renal Cell Carcinoma
• Thyroid Carcinoma

Snippet

Sponsor: University Medical Center Groningen | Conditions: Renal Cell Carcinoma, Ovarian Carcinoma | Phase 4 | Status: UNKNOWN